Table 1. Study cohort . Patient . Origin... | American Society of Hematology

Table 1.

Study cohort

	Patient	Origin	Demographic data		Clinical data								Analysis
	Patient	Origin	Sex	Age (y)	HL subtype	HIV status	HIV treatment	EBV status	Log₁₀VL (copies per mL) at HL diagnosis	CD4 T cells (cells per mm³) at HIV diagnosis	CD4 T cells (cells per mm³) at HL diagnosis	CD4 T cells (cells per mm³) currently	Analysis
HLposHIVnegEBVneg	1	Switzerland	M	33	LRHL	Negative	No	Negative by ISH					Imaging/HTG
	2	Switzerland	M	21	NSHL	Negative	No	Negative by ISH					Imaging/HTG
	3	Switzerland	F	21	NSHL	Negative	No	Negative by ISH					Imaging/HTG
	4	Switzerland	F	73	MCHL	Negative	No	Negative by ISH					Imaging/HTG/GeoMx
	5	Switzerland	F	30	NSHL	Negative	No	Negative by ISH					Imaging/HTG
	6	Switzerland	M	75	MCHL	Negative	No	Negative by ISH					Imaging/GeoMx
	7	Switzerland	M	44	NSHL	Negative	No	Negative by ISH					Imaging
	8	Switzerland	M	32	NSHL	Negative	No	Negative by ISH					Imaging
HLposHIVnegEBVpos	9	Switzerland	M	78	MCHL	Negative	No	Positive by ISH					Imaging/HTG
	10	Switzerland	F	76	MCHL	Negative	No	Positive by ISH					Imaging/HTG/GeoMx
	11	Switzerland	M	64	MCHL	Negative	No	Positive by ISH					Imaging/HTG/GeoMx
	12	Switzerland	M	36	MCHL	Negative	No	Positive by ISH					Imaging/HTG/GeoMx
	13	Switzerland	F	78	NSHL	Negative	No	Positive by ISH					Imaging/HTG
	14	Switzerland	M	50	NSHL	Negative	No	Positive by ISH					Imaging/HTG
	15	Switzerland	M	34	NSHL	Negative	No	Positive by ISH					Imaging/HTG
	16	Switzerland	M	78	MCHL	Negative	No	Positive by ISH					Imaging/HTG/GeoMx
	17	Switzerland	M	43	NSHL	Negative	No	Positive by ISH					Imaging
	18	Switzerland	M	54	MCHL	Negative	No	Positive by ISH					Imaging
	19	Switzerland	F	60	cHL	Negative	No	Positive by ISH					Imaging
	20	Switzerland	M	60	NSHL	Negative	No	Positive by ISH					Imaging
HLposHIVposEBVpos	21 (+ART)	Switzerland	M	59	NSHL	Positive	Yes	Positive by ISH	4.95	532	NA	NA	Imaging/HTG
	22 (+ART)	Switzerland	F	32	NSHL	Positive	Yes	Positive by ISH	<1.3	NA	NA	1227	Imaging/HTG
	23 (+ART)	Greece	M	43	MCHL	Positive	Yes	Positive by ISH	<1.6	928	717	1820	Imaging/HTG/GeoMx
	24	Greece	M	34	MCHL	Positive	No	Positive by ISH	4.96	340	327	680	Imaging/HTG/GeoMx
	25 (+ART)	Greece	M	37	MCHL	Positive	Yes	Positive by ISH	<1.3	963	341	776	Imaging/HTG/GeoMx
	26	Greece	F	26	LDHL	Positive	No	Positive by ISH	4.79	410	410	NA	Imaging/HTG
	27	Greece	M	52	LDHL	Positive	No	Positive by ISH	4.85	555	265	526	Imaging/HTG
	28 (+ART)	Greece	M	54	MCHL	Positive	Yes	Positive by ISH	2.64	298	259	252	Imaging/HTG/GeoMx
	29 (+ART)	Greece	M	44	NSHL	Positive	Yes	Positive by ISH	4.74	928	717	1820	Imaging/HTG

	Patient	Origin	Demographic data		Clinical data								Analysis
	Patient	Origin	Sex	Age (y)	HL subtype	HIV status	HIV treatment	EBV status	Log₁₀VL (copies per mL) at HL diagnosis	CD4 T cells (cells per mm³) at HIV diagnosis	CD4 T cells (cells per mm³) at HL diagnosis	CD4 T cells (cells per mm³) currently	Analysis
HLposHIVnegEBVneg	1	Switzerland	M	33	LRHL	Negative	No	Negative by ISH					Imaging/HTG
	2	Switzerland	M	21	NSHL	Negative	No	Negative by ISH					Imaging/HTG
	3	Switzerland	F	21	NSHL	Negative	No	Negative by ISH					Imaging/HTG
	4	Switzerland	F	73	MCHL	Negative	No	Negative by ISH					Imaging/HTG/GeoMx
	5	Switzerland	F	30	NSHL	Negative	No	Negative by ISH					Imaging/HTG
	6	Switzerland	M	75	MCHL	Negative	No	Negative by ISH					Imaging/GeoMx
	7	Switzerland	M	44	NSHL	Negative	No	Negative by ISH					Imaging
	8	Switzerland	M	32	NSHL	Negative	No	Negative by ISH					Imaging
HLposHIVnegEBVpos	9	Switzerland	M	78	MCHL	Negative	No	Positive by ISH					Imaging/HTG
	10	Switzerland	F	76	MCHL	Negative	No	Positive by ISH					Imaging/HTG/GeoMx
	11	Switzerland	M	64	MCHL	Negative	No	Positive by ISH					Imaging/HTG/GeoMx
	12	Switzerland	M	36	MCHL	Negative	No	Positive by ISH					Imaging/HTG/GeoMx
	13	Switzerland	F	78	NSHL	Negative	No	Positive by ISH					Imaging/HTG
	14	Switzerland	M	50	NSHL	Negative	No	Positive by ISH					Imaging/HTG
	15	Switzerland	M	34	NSHL	Negative	No	Positive by ISH					Imaging/HTG
	16	Switzerland	M	78	MCHL	Negative	No	Positive by ISH					Imaging/HTG/GeoMx
	17	Switzerland	M	43	NSHL	Negative	No	Positive by ISH					Imaging
	18	Switzerland	M	54	MCHL	Negative	No	Positive by ISH					Imaging
	19	Switzerland	F	60	cHL	Negative	No	Positive by ISH					Imaging
	20	Switzerland	M	60	NSHL	Negative	No	Positive by ISH					Imaging
HLposHIVposEBVpos	21 (+ART)	Switzerland	M	59	NSHL	Positive	Yes	Positive by ISH	4.95	532	NA	NA	Imaging/HTG
	22 (+ART)	Switzerland	F	32	NSHL	Positive	Yes	Positive by ISH	<1.3	NA	NA	1227	Imaging/HTG
	23 (+ART)	Greece	M	43	MCHL	Positive	Yes	Positive by ISH	<1.6	928	717	1820	Imaging/HTG/GeoMx
	24	Greece	M	34	MCHL	Positive	No	Positive by ISH	4.96	340	327	680	Imaging/HTG/GeoMx
	25 (+ART)	Greece	M	37	MCHL	Positive	Yes	Positive by ISH	<1.3	963	341	776	Imaging/HTG/GeoMx
	26	Greece	F	26	LDHL	Positive	No	Positive by ISH	4.79	410	410	NA	Imaging/HTG
	27	Greece	M	52	LDHL	Positive	No	Positive by ISH	4.85	555	265	526	Imaging/HTG
	28 (+ART)	Greece	M	54	MCHL	Positive	Yes	Positive by ISH	2.64	298	259	252	Imaging/HTG/GeoMx
	29 (+ART)	Greece	M	44	NSHL	Positive	Yes	Positive by ISH	4.74	928	717	1820	Imaging/HTG

cHL, classic Hodgkin Lymphoma; NSHL, Nodular Sclerosing HL; MCHL, Mixed Cellularity HL; LDHL, Lymphocyte Depleted HL; LRHL, Lymphocyte Rich HL.

View Large

This Feature Is Available To Subscribers Only